Literature DB >> 12517539

Lung cancer in Europe in 2000: epidemiology, prevention, and early detection.

Jerzy E Tyczynski1, Freddie Bray, D Maxwell Parkin.   

Abstract

Lung cancer is the most common cancer in the world. In men, the highest incidence rates are seen in Europe (especially eastern Europe) and North America. In women, high incidence rates are found in North America and in Europe, particularly in northern and western Europe. It is estimated that there were about 375000 cases of lung cancer in Europe in 2000; 303000 in men and 72000 in women. The number of resulting deaths was about 347000 (280000 in men and 67000 in women). Tobacco smoking is well established as the main cause of lung cancer and about 90% of cases are thought to be tobacco related. There is a clear dose-response relation between lung-cancer risk and the number of cigarettes smoked per day, degree of inhalation, and age at initiation of smoking. Someone who has smoked all their life has a lung-cancer risk 20-30 times greater than a non-smoker. However, risk of lung cancer decreases with time since smoking cessation. Recently, there has been renewed interest in screening because spiral computerised tomography can detect small asymptomatic lesions more effectively than conventional radiography. Although cure rates for such lesions are very good, there is to date no evidence for effectiveness of mass-screening strategies.

Entities:  

Mesh:

Year:  2003        PMID: 12517539     DOI: 10.1016/s1470-2045(03)00960-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  30 in total

1.  Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada.

Authors:  Ann C Olsson; Per Gustavsson; Hans Kromhout; Susan Peters; Roel Vermeulen; Irene Brüske; Beate Pesch; Jack Siemiatycki; Javier Pintos; Thomas Brüning; Adrian Cassidy; Heinz-Erich Wichmann; Dario Consonni; Maria Teresa Landi; Neil Caporaso; Nils Plato; Franco Merletti; Dario Mirabelli; Lorenzo Richiardi; Karl-Heinz Jöckel; Wolfgang Ahrens; Hermann Pohlabeln; Jolanta Lissowska; Neonila Szeszenia-Dabrowska; David Zaridze; Isabelle Stücker; Simone Benhamou; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Peter Rudnai; Eleonora Fabianova; Rodica Stanescu Dumitru; Isabelle M Gross; Benjamin Kendzia; Francesco Forastiere; Bas Bueno-de-Mesquita; Paul Brennan; Paolo Boffetta; Kurt Straif
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

2.  [Palliative radiation of bone metastasis in the spine for symptom control and stabilisation: indication and limits].

Authors:  Angelika Drobil-Unterberger
Journal:  Wien Med Wochenschr       Date:  2006-05

3.  [Palliative therapy in bronchial carcinoma--implanted delivery system and ports].

Authors:  Thomas Reif-Gintl; Wilfried Ilias
Journal:  Wien Med Wochenschr       Date:  2008

4.  RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.

Authors:  Ya-Nan Liang; Yu Liu; Qingwei Meng; Xiaobo Li; Fan Wang; Guodong Yao; Letian Wang; Songbin Fu; Dandan Tong
Journal:  Med Oncol       Date:  2015-01-15       Impact factor: 3.064

5.  Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.

Authors:  P Mota; H C Silva; M J Soares; A Pego; M Loureiro; C Robalo Cordeiro; F J Regateiro
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-12       Impact factor: 4.553

Review 6.  The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer.

Authors:  Sara Volpi; Jason M Ali; Angela Tasker; Adam Peryt; Giuseppe Aresu; Aman S Coonar
Journal:  Ann Transl Med       Date:  2018-03

7.  Low cancer incidence rates in Ohio Amish.

Authors:  Judith A Westman; Amy K Ferketich; Ross M Kauffman; Steven N MacEachern; J R Wilkins; Patricia P Wilcox; Robert T Pilarski; Rebecca Nagy; Stanley Lemeshow; Albert de la Chapelle; Clara D Bloomfield
Journal:  Cancer Causes Control       Date:  2009-09-25       Impact factor: 2.506

8.  Cancer risk is not increased after conventional hip arthroplasty.

Authors:  Tuomo Visuri; Pekka Pulkkinen; Pekka Paavolainen; Eero Pukkala
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

9.  A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status.

Authors:  W J Louwman; M J Aarts; S Houterman; F J van Lenthe; J W W Coebergh; M L G Janssen-Heijnen
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

10.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.